Postmenopausal estrogen replacement therapy and risk of developing systemic lupus erythematosus or discoid lupus.
作者信息
Petri M
出版信息
J Rheumatol. 1999 Mar;26(3):752.
PMID:10090197
Abstract
摘要
相似文献
1
2
3
[Estrogen use in systemic lupus erythematosus].[雌激素在系统性红斑狼疮中的应用]
Gynecol Obstet Fertil. 2005 Oct;33(10):783-90. doi: 10.1016/j.gyobfe.2005.06.021.
4
[Is postmenopausal estrogen replacement contraindicated in systemic lupus erythematosus?].绝经后雌激素替代疗法在系统性红斑狼疮中是否禁忌？
Internist (Berl). 1994 Jun;35(6):579.
5
Hormone replacement therapy: estrogen after menopause.激素替代疗法：绝经后的雌激素。
Pharmacotherapy. 1996 May-Jun;16(3):366-75.
6
[Hormonal therapy in systemic lupus erythematosus].[系统性红斑狼疮的激素治疗]
Reumatizam. 2009;56(2):41-3.
7
Female hormone therapy and the risk of developing or exacerbating systemic lupus erythematosus or rheumatoid arthritis.女性激素疗法与发生或加重系统性红斑狼疮或类风湿关节炎的风险。
Proc Assoc Am Physicians. 1996 Jan;108(1):25-8.
8
Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.绝经后激素替代疗法与急性胰腺炎风险：一项基于人群的病例对照研究。
Am J Gastroenterol. 2007 Feb;102(2):275-8. doi: 10.1111/j.1572-0241.2006.00924.x.
9
10
[Lupus erythematosus of drug origin].药物性红斑狼疮
Lyon Med. 1971;18:Suppl:77-8.
引用本文的文献
1
Sex and gender influence on immunity and autoimmunity.性别和性征对免疫和自身免疫的影响。
Front Immunol. 2023 May 26;14:1142723. doi: 10.3389/fimmu.2023.1142723. eCollection 2023.
2
Lupuzor/P140 peptide in patients with systemic lupus erythematosus: a randomised, double-blind, placebo-controlled phase IIb clinical trial.系统性红斑狼疮患者中 Lupuzor/P140 肽：一项随机、双盲、安慰剂对照的 IIb 期临床试验。
Ann Rheum Dis. 2013 Nov;72(11):1830-5. doi: 10.1136/annrheumdis-2012-202460. Epub 2012 Nov 21.
Zotero 插件